The emperor's new clothes [3]

Journal of Vascular and Interventional Radiology

Volumn 16, Issue 4, 2005, Pages 561-562

  Murphy, Kieran ^a   Nussbaum, David A ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROFECOXIB;

COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; HEALTH CARE; HUMAN; KYPHOPLASTY; LETTER; MEDICAL DECISION MAKING; MEDICAL RESEARCH; OSTEOPOROSIS; PERCUTANEOUS VERTEBROPLASTY; PRIORITY JOURNAL;

EID: 16244370095     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000151925.66559.25     Document Type: Letter

References (17)

1. Lieberman IH, Phillips FM, Togawa D, et al. Vertebral augmentation and the limits of interpreting complications reported in the Food and Drug Administration manufacturer and user facility device experience database. J Vasc Interv Radiol 2004; 15:1193-1196.
2. Nussbaum DA, Gailloud P, Murphy K. A review of complications associated with vertebroplasty and kyphoplasty as reported to the food and drug administration medical device related web site. J Vasc Interv Radiol 2004; 15:1185-1192.
3. st, 2004.
4. Wilson DR, Myers ER, Mathis JM, et al. Effect of augmentation on the mechanics of vertebral wedge fractures. Spine 1999; 25:158-165.
5. Belkoff SM, Jasper LE, Stevens SS. An ex vivo evaluation of an inflatable bone tamp used to reduce fractures within vertebral bodies under load. Spine 2002; 27:1640-1643.
6. Lieberman IH, Dudeney S, Reinhardt MK, Bell G. Initial outcome and efficacy of "kyphoplasty" in the treatment of painful osteoporotic vertebral compression fractures. Spine 2001; 26:1631-1638.
7. Lee ST, Chen JF. Closed reduction vertebroplasty for the treatment of osteoporotic vertebral compression fractures. Technical note. J Neurosurg Spine 2004; 100:392-396.
8. McKiernan F, Jensen R, Faciszewski T. The dynamic mobility of vertebral compression fractures. J Bone Miner Res. 2003 1;24-29.
9. Teng MM, Wei CJ, Wei LC, et al. Kyphosis correction and height restoration effects of percutaneous vertebroplasty. Spine 2002; 27:1640-1643.
10. Fribourg D, Tang C, Sra P, Delamarter R, Bae H. Incidence of subsequent vertebral fracture after kyphoplasty. Spine 2004; 29:2270-2276.
11. Harrop JS, Prpa B, Reinhardt MK, Lieberman I. Primary and secondary osteoporosis' incidence of subsequent vertebral compression fractures after kyphoplasty. Spine 2004; 29:2120-2125.
12. Uppin AA, Hirsch JA, Centenera LV, Pfiefer BA, Pazianos AG, Choi IS. Occurrence of new vertebral body fracture after percutaneous vertebroplasty in patients with osteoporosis. Radiology 2003; 226:119-124.
13. Health Research Institute. U.S. markets for adjunctive and non-fusion spine technologies. Medtech Insights 2003; Report #103-1-US-0103.
14. th, 2003. http://kyph.client.shareholder.com/downloads/3QTranscript.pdf.
15. Garfin SR, Yuan HA, Reiley MA. New technologies in spine: kyphoplasty and vertebroplasty for the treatment of painful osteoporotic compression fractures. Spine 2001; 26:1511-1515.
16. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001;286:954-959.
17. Konstam MA, Demopoulos LA. Letters to Editor, re: risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001; 286:2811-2812.